Clinical trials recruiting in Bourdeaux, France

Phase breakdown

Conditions recruiting in Bourdeaux, France

Recruiting trials in Bourdeaux, France

• Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
  NCT05918302 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Rheopheresis as Adjuvant Treatment of Calciphylaxis
  NCT04654000 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
  NCT05433142 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients
  NCT04405583 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Bourdeaux, France?

4 recruiting trials have at least one study site in Bourdeaux, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.